Vimarsana
Biggest News Aggregation in the World

Page 13 - Philipp Mathieu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philipp Mathieu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philipp Mathieu Today - Breaking & Trending Today

Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states - Vimarsana News

Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states

/PRNewswire/ -- The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical...

Immunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access US - Vimarsana News

Immunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access US

LUND, Sweden, May 16, 2022 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Natalie...

Immunovia Publishes Interim Report January-March 2022 - Vimarsana News

Immunovia Publishes Interim Report January-March 2022

/PRNewswire/ -- January-March Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123) Net earnings...

Immunovia AB: Immunovia Publishes Interim Report January-March 2022 - Vimarsana News

Immunovia AB: Immunovia Publishes Interim Report January-March 2022

STOCKHOLM, April 28, 2022 /PRNewswire/ -- January-March Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123)Net earnings amounted

Immunovia Publishes Interim Report January-March 2022 - Vimarsana News

Immunovia Publishes Interim Report January-March 2022

/PRNewswire/ -- January-March Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123) Net earnings...